ArticleEuropean heart journal open2023

Effectiveness of icosapent ethyl on first and total cardiovascular events in patients with metabolic syndrome, but without diabetes: REDUCE-IT MetSyn.

Michael Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.